Cargando…

Adiponectin: friend or foe in obesity and inflammation

Adiponectin is an adipokine predominantly produced by fat cells, circulates and exerts insulin-sensitizing, cardioprotective and anti-inflammatory effects. Dysregulation of adiponectin and/or adiponectin signaling is implicated in a number of metabolic diseases such as obesity, insulin resistance, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Liping, Liu, Meilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388816/
https://www.ncbi.nlm.nih.gov/pubmed/37724325
http://dx.doi.org/10.1515/mr-2022-0002
_version_ 1785082203904933888
author Luo, Liping
Liu, Meilian
author_facet Luo, Liping
Liu, Meilian
author_sort Luo, Liping
collection PubMed
description Adiponectin is an adipokine predominantly produced by fat cells, circulates and exerts insulin-sensitizing, cardioprotective and anti-inflammatory effects. Dysregulation of adiponectin and/or adiponectin signaling is implicated in a number of metabolic diseases such as obesity, insulin resistance, diabetes, and cardiovascular diseases. However, while the insulin-sensitizing and cardioprotective effects of adiponectin have been widely appreciated in the field, the obesogenic and anti-inflammatory effects of adiponectin are still of much debate. Understanding the physiological function of adiponectin is critical for adiponectin-based therapeutics for the treatment of metabolic diseases.
format Online
Article
Text
id pubmed-10388816
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-103888162023-09-18 Adiponectin: friend or foe in obesity and inflammation Luo, Liping Liu, Meilian Med Rev (Berl) Review Adiponectin is an adipokine predominantly produced by fat cells, circulates and exerts insulin-sensitizing, cardioprotective and anti-inflammatory effects. Dysregulation of adiponectin and/or adiponectin signaling is implicated in a number of metabolic diseases such as obesity, insulin resistance, diabetes, and cardiovascular diseases. However, while the insulin-sensitizing and cardioprotective effects of adiponectin have been widely appreciated in the field, the obesogenic and anti-inflammatory effects of adiponectin are still of much debate. Understanding the physiological function of adiponectin is critical for adiponectin-based therapeutics for the treatment of metabolic diseases. De Gruyter 2022-07-01 /pmc/articles/PMC10388816/ /pubmed/37724325 http://dx.doi.org/10.1515/mr-2022-0002 Text en © 2022 the author(s), published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Review
Luo, Liping
Liu, Meilian
Adiponectin: friend or foe in obesity and inflammation
title Adiponectin: friend or foe in obesity and inflammation
title_full Adiponectin: friend or foe in obesity and inflammation
title_fullStr Adiponectin: friend or foe in obesity and inflammation
title_full_unstemmed Adiponectin: friend or foe in obesity and inflammation
title_short Adiponectin: friend or foe in obesity and inflammation
title_sort adiponectin: friend or foe in obesity and inflammation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388816/
https://www.ncbi.nlm.nih.gov/pubmed/37724325
http://dx.doi.org/10.1515/mr-2022-0002
work_keys_str_mv AT luoliping adiponectinfriendorfoeinobesityandinflammation
AT liumeilian adiponectinfriendorfoeinobesityandinflammation